US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines
Patent 7709502 was granted and assigned to Celgene on May, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
